NCT03833830View on ClinicalTrials.gov

Vessel Density in nAMD After Longterm Anti-VEGF Treatment Compared to Recently Started Anti-VEGF Treatment

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

January 7, 2019

Primary Completion Date

April 2, 2019

Study Completion Date

May 30, 2019

Conditions
Neovascular Age-related Macular Degeneration
Interventions
DIAGNOSTIC_TEST

Optical Coherence Tomography angiography (OCTA)

There will be an OCTA measurement (observational study) for both groups. Group allocation will be made due to previous anti-VEGF treatments (longterm treatment group \>20 injections and shortterm treatment group \< 5 injections).

Trial Locations (1)

4102

Vista Klinik, Binningen

All Listed Sponsors
collaborator

Cenaug Foundation

UNKNOWN

lead

Dr. med. Katja Hatz

OTHER

NCT03833830 - Vessel Density in nAMD After Longterm Anti-VEGF Treatment Compared to Recently Started Anti-VEGF Treatment | Biotech Hunter | Biotech Hunter